COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence

BACKGROUND: Managing severe asthma during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is challenging, particularly due to safety concerns regarding the use of systemic corticosteroids and biologics. OBJECTIVES: We sought to determine the association between biologics or...

Descripción completa

Detalles Bibliográficos
Autores principales: Adir, Yochai, Humbert, Marc, Saliba, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205279/
https://www.ncbi.nlm.nih.gov/pubmed/34144110
http://dx.doi.org/10.1016/j.jaci.2021.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205279/
https://www.ncbi.nlm.nih.gov/pubmed/34144110
http://dx.doi.org/10.1016/j.jaci.2021.06.006

Ejemplares similares